Furthermore, anti-CSF-1/CSF-1R therapies have produced encouraging therapeutic responses in pre-clinical tumour models, particularly in combination with chemotherapy or radiotherapy [72,73,74], or when used to reprogram tumor-promoting TAMs into anti-tumoral TAMs [69,75]. The gene discussed is CSF1R; the disease is neoplasm.